Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Breuer

Showing results (121-130 of 139) with videos related to

Pageof 14
Sort By:
Journal of Lipid Research|November 22, 2024
The antidepressant drug sertraline is a novel inhibitor of yeast Pah1 and human lipin 1 phosphatidic acid phosphatasesGeordan J Stukey, Matthew R Breuer, Natalie Burchat, et al.
Journal of Lipid Research|October 31, 2025
Erratum to: The antidepressant drug sertraline is a novel inhibitor of yeast Pah1 and human lipin 1 phosphatidic acid phosphatases [Journal of Lipid Research 66/1 (2025) 100711]Geordan J Stukey, Matthew R Breuer, Natalie Burchat, et al.
American Journal of Respiratory and Critical Care Medicine|April 1, 1995
Elastin and collagen degradation products in urine of smokers with and without chronic obstructive pulmonary diseaseP J Stone, D J Gottlieb, G T O'Connor, et al.
The Journal of Surgical Research|June 22, 2023
Patient and Provider Perceptions About Communication After Bariatric Surgery: A Qualitative AnalysisChloe S Lam, Esra Alagoz, Dawda Jawara, et al.
Molecular Psychiatry|July 24, 2009
Supporting evidence for LRRTM1 imprinting effects in schizophreniaK U Ludwig, M Mattheisen, T W Mühleisen, et al.
Translational Psychiatry|October 25, 2012
Genome-wide association of mood-incongruent psychotic bipolar disorderF S Goes, M L Hamshere, F Seifuddin, et al.
Molecular Psychiatry|June 16, 2010
Independent evidence for the selective influence of GABA(A) receptors on one component of the bipolar disorder phenotypeR Breuer, M L Hamshere, J Strohmaier, et al.
Contemporary Clinical Trials|June 24, 2024
The TOTAL trial for weight management participation: A randomized controlled trial protocolLuke M Funk, Christine B Williams, Catherine R Breuer, et al.
Annals of Surgical Oncology|January 29, 2025
Ongoing Symptoms and Concerns Experienced by Low-Risk Breast Cancer Survivors Following Active TreatmentJessica R Schumacher, Jennifer L Tucholka, Catherine R Breuer, et al.
Molecular Psychiatry|December 18, 2008
Two variants in Ankyrin 3 (ANK3) are independent genetic risk factors for bipolar disorderT G Schulze, S D Detera-Wadleigh, N Akula, et al.
Pageof 14

Showing results (121-130 of 139) with videos related to

Sort By:
Pageof 14
Journal of Lipid Research|November 22, 2024
The antidepressant drug sertraline is a novel inhibitor of yeast Pah1 and human lipin 1 phosphatidic acid phosphatasesGeordan J Stukey, Matthew R Breuer, Natalie Burchat, et al.
Journal of Lipid Research|October 31, 2025
Erratum to: The antidepressant drug sertraline is a novel inhibitor of yeast Pah1 and human lipin 1 phosphatidic acid phosphatases [Journal of Lipid Research 66/1 (2025) 100711]Geordan J Stukey, Matthew R Breuer, Natalie Burchat, et al.
American Journal of Respiratory and Critical Care Medicine|April 1, 1995
Elastin and collagen degradation products in urine of smokers with and without chronic obstructive pulmonary diseaseP J Stone, D J Gottlieb, G T O'Connor, et al.
The Journal of Surgical Research|June 22, 2023
Patient and Provider Perceptions About Communication After Bariatric Surgery: A Qualitative AnalysisChloe S Lam, Esra Alagoz, Dawda Jawara, et al.
Molecular Psychiatry|July 24, 2009
Supporting evidence for LRRTM1 imprinting effects in schizophreniaK U Ludwig, M Mattheisen, T W Mühleisen, et al.
Translational Psychiatry|October 25, 2012
Genome-wide association of mood-incongruent psychotic bipolar disorderF S Goes, M L Hamshere, F Seifuddin, et al.
Molecular Psychiatry|June 16, 2010
Independent evidence for the selective influence of GABA(A) receptors on one component of the bipolar disorder phenotypeR Breuer, M L Hamshere, J Strohmaier, et al.
Contemporary Clinical Trials|June 24, 2024
The TOTAL trial for weight management participation: A randomized controlled trial protocolLuke M Funk, Christine B Williams, Catherine R Breuer, et al.
Annals of Surgical Oncology|January 29, 2025
Ongoing Symptoms and Concerns Experienced by Low-Risk Breast Cancer Survivors Following Active TreatmentJessica R Schumacher, Jennifer L Tucholka, Catherine R Breuer, et al.
Molecular Psychiatry|December 18, 2008
Two variants in Ankyrin 3 (ANK3) are independent genetic risk factors for bipolar disorderT G Schulze, S D Detera-Wadleigh, N Akula, et al.
Pageof 14